Rani Therapeutics Holdings Inc (NASDAQ:RANI) price on Thursday, July 03, rose 0.68% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.54.
A look at the stock’s price movement, the close in the last trading session was $0.53, moving within a range at $0.5242 and $0.55. The beta value (5-Year monthly) was -0.0. Turning to its 52-week performance, $4.19 and $0.46 were the 52-week high and 52-week low respectively. Overall, RANI moved -3.44% over the past month.
Rani Therapeutics Holdings Inc’s market cap currently stands at around $30.81 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RANI is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend RANI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RANI’s current price about 0.99% and -21.96% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.24, while 7-day volatility ratio is 7.62% and 7.02% in the 30-day chart. Further, Rani Therapeutics Holdings Inc (RANI) has a beta value of -0.03. Analysts have given the company’s stock an average 52-week price target of $10, forecast between a low of $9 and high of $28. Looking at the price targets, the low is -1566.67% off current price level while to achieve the yearly target high, price needs to move -5085.19%. Nonetheless, investors will most likely welcome a -1751.85% jump to $10 which is the analysts’ median price.
If we refocus on Rani Therapeutics Holdings Inc (NASDAQ:RANI), historical trading data shows that trading volumes averaged 0.31 over the past 10 days and 455.24K over the past 3 months. The company’s latest data on shares outstanding shows there are 33.57 million shares.
The 32.10% of Rani Therapeutics Holdings Inc’s shares are in the hands of company insiders while institutional holders own 7.34% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.63 million on 2025-06-13, giving us a short ratio of 4.68. The data shows that as of 2025-06-13 short interest in Rani Therapeutics Holdings Inc (RANI) stood at 1530.0 of shares outstanding, with shares short rising to 2.94 million registered in 2025-05-15. Current price change has pushed the stock -85.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RANI stock continues to rise going into the next quarter.
